Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00996684
What this trial is testing

Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
University of California, Los Angeles 30
Not applicableStudy completedNCT02227498
What this trial is testing

Argus II Retinal Prosthesis System Dry AMD Feasibility Study Protocol

Who this might be right for
Age Related Macular Degeneration
Second Sight Medical Products 5
Not applicableNot Yet RecruitingNCT07700147
What this trial is testing

Evaluation of an Electric Stimulator for Medical Use by Personal (LRTPM1) for Visual Function in Early to Intermediate Dry Age-Related Macular Degeneration

Who this might be right for
Dry Age-Related Macular DegenerationAMD
Nu Eyne Co., Ltd. 40
Early research (Phase 1)UnknownNCT03772938
What this trial is testing

Stem Cells Therapy in Degenerative Diseases of the Retina

Who this might be right for
Retinal DegenerationRetinitis PigmentosaAge Related Macular Degeneration+1 more
Pomeranian Medical University Szczecin 30
Not applicableUnknownNCT03760055
What this trial is testing

Assessment of Visual Function With a Portable Brain-computer Interface

Who this might be right for
GlaucomaAge Related Macular DegenerationOptic Neuropathy+1 more
NGoggle 200
Not applicableStudy completedNCT02909985
What this trial is testing

Visual Activity Evoked by Infrared in Humans After Dark Adaptation

Who this might be right for
Age Related Macular DegenerationRetinitis PigmentosaCongenital Stationary Night Blindness+1 more
University of New Mexico 21
Large-scale testing (Phase 3)Study completedNCT01908816
What this trial is testing

An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.

Who this might be right for
Choroidal NeovascularizationMacular EdemaGlaucoma, Neovascular+1 more
Novartis Pharmaceuticals 270
Post-approval studies (Phase 4)WithdrawnNCT01666236
What this trial is testing

Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy

Who this might be right for
Choroidal NeovascularizationRetinal Pigment Epithelial Detachment
Federal University of São Paulo
Post-approval studies (Phase 4)Ended earlyNCT04563299
What this trial is testing

Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Retina Vitreous Associates of Florida 10
Not applicableStudy completedNCT01316198
What this trial is testing

Effects of Xanthophylls on Optical Density

Who this might be right for
Age-Related Macular Degeneration
University of Jena 20
Early research (Phase 1)Study completedNCT06006585
What this trial is testing

Test How Well Different Doses of BI 771716 Are Tolerated by People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

Who this might be right for
Geographic Atrophy
Boehringer Ingelheim 20
Testing effectiveness (Phase 2)Study completedNCT02684578
What this trial is testing

Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD

Who this might be right for
Age-Related Macular DegenerationMacular Degeneration, Age-RelatedDry Macular Degeneration+1 more
University of California, San Francisco 66
Not applicableEnded earlyNCT01994174
What this trial is testing

Effect of Vascular Endothelial Growth Factor Blockers on Aqueous Humor Dynamics

Who this might be right for
Macular Disease
University of Nebraska 13
Large-scale testing (Phase 3)Study completedNCT00473382
What this trial is testing

Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RIDE)

Who this might be right for
Diabetes MellitusMacular Edema
Genentech, Inc. 382
Not applicableWithdrawnNCT00956124
What this trial is testing

Autofluorescence in Uveitic and Diabetic Macular Edema

Who this might be right for
UveitisMacular Edema
St. Franziskus Hospital
Large-scale testing (Phase 3)Study completedNCT00168324
What this trial is testing

The Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Allergan 599
Post-approval studies (Phase 4)Looking for participantsNCT05093374
What this trial is testing

Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting

Who this might be right for
Exudative Macular Degeneration
Medical University of Vienna 290
Not applicableStudy completedNCT05920655
What this trial is testing

Comparison of Ocular Changes by Surgical Menopause Using Optical Coherence Tomography (OCT)

Who this might be right for
Corneal DeformityMacular Degeneration AdvancedSurgical Menopause
Batman Training and Research Hospital 100
Not applicableStudy completedNCT00858208
What this trial is testing

Efficacy And Safety Of Macugen In Patients With Neovascular AMD In Routine Clinical Practice.

Who this might be right for
Neovascular Age-related Macular Degeneration
Pfizer 86
Not applicableStudy completedNCT04776031
What this trial is testing

Evaluation of R:GEN as Intervention in Subjects With Early Stages of AMD for Safety and Exploratory Efficacy Outcomes

Who this might be right for
Early Age Related Macular Degeneration (Disorder)
Lutronic Vision, Inc 31
Next Page